State Street Corp lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.2% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 45,703,591 shares of the healthcare conglomerate’s stock after purchasing an additional 70,324 shares during the quarter. State Street Corp owned approximately 0.05% of UnitedHealth Group worth $16,776,874,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also bought and sold shares of the company. BlackRock Inc. lifted its holdings in shares of UnitedHealth Group by 4.6% in the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after purchasing an additional 3,395,530 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in UnitedHealth Group by 6.1% during the second quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate’s stock worth $4,449,317,000 after buying an additional 616,723 shares in the last quarter. Wellington Management Group LLP raised its position in UnitedHealth Group by 5.8% in the 2nd quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate’s stock valued at $4,436,923,000 after buying an additional 583,536 shares during the last quarter. Fisher Asset Management LLC lifted its stake in UnitedHealth Group by 19.2% during the 3rd quarter. Fisher Asset Management LLC now owns 10,829,637 shares of the healthcare conglomerate’s stock valued at $3,975,343,000 after acquiring an additional 1,747,368 shares in the last quarter. Finally, Corient Private Wealth LP boosted its holdings in UnitedHealth Group by 1,443.7% during the 2nd quarter. Corient Private Wealth LP now owns 8,447,224 shares of the healthcare conglomerate’s stock worth $3,510,920,000 after acquiring an additional 7,900,011 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.
Wall Street Analysts Forecast Growth
UNH has been the subject of several analyst reports. UBS Group reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday, October 13th. Zacks Research downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 14th. Weiss Ratings upgraded shares of UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, October 8th. Wall Street Zen raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Finally, Royal Bank Of Canada upped their target price on UnitedHealth Group from $478.00 to $498.00 and gave the company an “outperform” rating in a report on Tuesday, October 20th. Twenty-one analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $465.70.
Check Out Our Latest Analysis on UNH
UnitedHealth Group Price Performance
UNH opened at $339.92 on Friday. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62. The company has a market capitalization of $304.57 billion, a price-to-earnings ratio of 19.41, a PEG ratio of 1.49 and a beta of 0.51. The firm has a 50-day moving average price of $388.64 and a 200-day moving average price of $367.55.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The business had revenue of $112.72 billion during the quarter, compared to the consensus estimate of $111.31 billion. During the same quarter last year, the company earned $2.59 EPS. The firm’s revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be given a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date is Monday, December 7th. UnitedHealth Group’s dividend payout ratio (DPR) is 53.00%.
UnitedHealth Group News Roundup
Investors following UNH have been watching these news items:
- Positive Sentiment: TD Cowen raised its rating on UnitedHealth to Buy from Hold, increased its price target to $455 from $402, and named it a 2027 best idea. The firm sees a clearer path to stronger earnings as Medicare Advantage pricing becomes more rational, with mid-to-high-teens EPS growth possible. Article: UnitedHealth stock pops on Buy rating, price target raise from TD Cowen
- Negative Sentiment: A law firm announced an investigation into potential securities-law or business-practice violations by UnitedHealth or its senior management. The notice does not establish wrongdoing, but adds legal and reputational uncertainty. Article: UnitedHealth Group investigation notice
- Negative Sentiment: Investors remain concerned about proposed CMS Medicare Advantage audit and repayment rules, which could extend audit findings across contracts and reach back to earlier payment years. Those concerns have weighed on managed-care stocks and contributed to UnitedHealth’s recent decline. Article: UnitedHealth Shares Sink as New Federal Fraud Crackdown Sparks Healthcare Sell-Off
UnitedHealth Group Company Profile
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
Further Reading
- Five stocks we like better than UnitedHealth Group
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
